DONATE

3D printing biocompatible hydrogels

IBEC researchers have laid the groundwork for faster advances in 3D bioprinting for regenerative medicine by creating a system of ink and matrices that offers a solid basis for tissue regeneration.

Due to their high water content, hydrogels are highly attractive biomaterials for 3D printing as efficient ‘surrogates’ for the extracellular matrix, onto which cells can be cultured. However, while they are relatively easy to produce using a method called extrusion printing, their stability and structural integrity can weaken when they’re in contact with biological fluids or extracellular matrices.

10th Annual Conference of Biomedical Research Technology Platforms

The Spanish Platform for Nanomedicine (NanoMedSpain), led by IBEC Director Josep Samitier, is participating once again in the Annual Conference of Technological Platforms of Biomedical Research in Madrid this week.

This year, NanoMed Spain has invited Pier Maria Fornasari, Director of Complex Structures at the Instituto Ortopedico Rizzoli di Bologna. He will represent the ‘Biofabrication for Regenerative Medicine’ joint proposal sent to the European Commission in response to their call for new FET Flagship initiatives for the next work program.

IBEC at the Mobile World Congress

This week IBEC is taking part in the Youth Mobile Festival (YOMO) of the Mobile World Congress, the world’s largest gathering for the mobile industry, with an interactive stand about bioengineering for cardiac regeneration.

Members of the Biomaterials for Regenerative Therapies group, Soledad Pérez, Jesús Ordoño and Gerard Rubí, will explain the research carried out to regenerate the heart using biodegradable and bioactive materials. With the aid of a 3D pen, attendees will be able to replicate one of the techniques that are used for research in this area.

Visitors and Sabbaticals

Internationalization is at the core of IBEC’s scientific and training strategy. Actions enhancing IBEC’s international profile are designed to foster exchange in complementary techniques and trigger new collaborations, as well … Read more

A new therapeutic target that could slow the progression of Parkinson’s disease

Researchers at IBEC have identified a potential way to slow down the neurodegenerative progression of Parkinson’s disease.

They focused their work on the cellular prion protein (PrPc), a specialized molecule located in the membranes of neurons that’s involved in a number of functions such as cell cycle control and neurotransmission.